Literature DB >> 25264619

CDC6 controls dynamics of the first embryonic M-phase entry and progression via CDK1 inhibition.

Mohammed El Dika1, Katarzyna Laskowska-Kaszub1, Magdalena Koryto2, Damian Dudka1, Claude Prigent1, Jean-Pierre Tassan1, Malgorzata Kloc3, Zbigniew Polanski4, Ewa Borsuk2, Jacek Z Kubiak5.   

Abstract

CDC6 is essential for S-phase to initiate DNA replication. It also regulates M-phase exit by inhibiting the activity of the major M-phase protein kinase CDK1. Here we show that addition of recombinant CDC6 to Xenopus embryo cycling extract delays the M-phase entry and inhibits CDK1 during the whole M-phase. Down regulation of endogenous CDC6 accelerates the M-phase entry, abolishes the initial slow and progressive phase of histone H1 kinase activation and increases the level of CDK1 activity during the M-phase. All these effects are fully rescued by the addition of recombinant CDC6 to the extracts. Diminution of CDC6 level in mouse zygotes by two different methods results in accelerated entry into the first cell division showing physiological relevance of CDC6 in intact cells. Thus, CDC6 behaves as CDK1 inhibitor regulating not only the M-phase exit, but also the M-phase entry and progression via limiting the level of CDK1 activity. We propose a novel mechanism of M-phase entry controlled by CDC6 and counterbalancing cyclin B-mediated CDK1 activation. Thus, CDK1 activation proceeds with concomitant inhibition by CDC6, which tunes the timing of the M-phase entry during the embryonic cell cycle.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDC6; CDK1; Cell-free extract; Embryo; M-phase entry; Mouse zygote; NCTD; Xenopus laevis

Mesh:

Substances:

Year:  2014        PMID: 25264619     DOI: 10.1016/j.ydbio.2014.09.023

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  5 in total

Review 1.  Genome Duplication: The Heartbeat of Developing Organisms.

Authors:  Melvin L DePamphilis
Journal:  Curr Top Dev Biol       Date:  2016-01-20       Impact factor: 4.897

Review 2.  DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells.

Authors:  Shaoran Song; Yaochun Wang; Peijun Liu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

3.  Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells.

Authors:  Yue He; Daoyu Yan; Dianpeng Zheng; Zhiming Hu; Hongwei Li; Jinlong Li
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

4.  Nrf2 inhibition affects cell cycle progression during early mouse embryo development.

Authors:  Ying Lin; Liu-Cai Sui; Rong-Hua Wu; Ru-Jun Ma; Hai-Yan Fu; Juan-Juan Xu; Xu-Hua Qiu; Li Chen
Journal:  J Reprod Dev       Date:  2017-12-16       Impact factor: 2.214

5.  Mathematical Model Explaining the Role of CDC6 in the Diauxic Growth of CDK1 Activity during the M-Phase of the Cell Cycle.

Authors:  Mateusz Dębowski; Zuzanna Szymańska; Jacek Z Kubiak; Mirosław Lachowicz
Journal:  Cells       Date:  2019-11-28       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.